Since 1901, Teva has a portfolio consisting of over 3,600 products in nearly every therapeutic area and serves nearly 200 million people worldwide every day. Teva China has offices in SH, BJ and HK with 140+ employees. Teva China has already launched 2 medicines in Mainland China: Treanda ® and Austedo®. Copaxone® was also approved in June, which will continue to bring benefits to Chinese patient